Park Avenue Securities LLC Acquires 6,720 Shares of Xometry, Inc. $XMTR

Park Avenue Securities LLC acquired a new position in shares of Xometry, Inc. (NASDAQ:XMTR) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 6,720 shares of the company’s stock, valued at approximately $691,000.

Several other institutional investors and hedge funds have also made changes to their positions in XMTR. Capelight Capital Asset Management LP increased its holdings in shares of Xometry by 20.7% in the 3rd quarter. Capelight Capital Asset Management LP now owns 36,200 shares of the company’s stock valued at $3,723,000 after acquiring an additional 6,200 shares during the last quarter. Sterling Capital Management LLC lifted its stake in Xometry by 949.7% during the third quarter. Sterling Capital Management LLC now owns 1,711 shares of the company’s stock worth $176,000 after purchasing an additional 1,548 shares during the last quarter. Inspire Investing LLC purchased a new stake in Xometry during the third quarter worth approximately $631,000. Abel Hall LLC boosted its holdings in Xometry by 5.2% in the third quarter. Abel Hall LLC now owns 2,246 shares of the company’s stock valued at $231,000 after purchasing an additional 111 shares in the last quarter. Finally, IFP Advisors Inc boosted its holdings in Xometry by 687.5% in the third quarter. IFP Advisors Inc now owns 441 shares of the company’s stock valued at $45,000 after purchasing an additional 385 shares in the last quarter. 97.31% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Xometry

In other news, Director Katharine Weymouth sold 5,000 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $95.23, for a total value of $476,150.00. Following the completion of the sale, the director directly owned 35,345 shares of the company’s stock, valued at approximately $3,365,904.35. This represents a 12.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Sanjeev Sahni sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $108.80, for a total transaction of $163,200.00. Following the transaction, the chief executive officer owned 178,291 shares in the company, valued at approximately $19,398,060.80. This trade represents a 0.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 63,199 shares of company stock valued at $6,037,855 over the last ninety days. 9.10% of the stock is owned by insiders.

Xometry Stock Up 2.0%

Xometry stock opened at $113.52 on Thursday. Xometry, Inc. has a fifty-two week low of $35.86 and a fifty-two week high of $117.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21. The company has a market capitalization of $5.88 billion, a P/E ratio of -333.87 and a beta of 1.33. The stock has a 50-day simple moving average of $97.42 and a 200-day simple moving average of $76.71.

Xometry (NASDAQ:XMTR) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. The firm had revenue of $252.44 million for the quarter, compared to the consensus estimate of $235.54 million. Xometry had a positive return on equity of 0.20% and a negative net margin of 1.97%. The firm’s quarterly revenue was up 39.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.11 EPS. Equities research analysts expect that Xometry, Inc. will post -0.01 earnings per share for the current year.

Analyst Ratings Changes

XMTR has been the topic of a number of research analyst reports. BNP Paribas Exane began coverage on shares of Xometry in a report on Friday, September 18th. They set an “outperform” rating and a $120.00 price objective on the stock. The Goldman Sachs Group boosted their price objective on shares of Xometry from $78.00 to $104.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada upped their target price on shares of Xometry from $100.00 to $117.00 and gave the company a “sector perform” rating in a report on Wednesday. Citigroup increased their target price on shares of Xometry from $110.00 to $132.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Cantor Fitzgerald lifted their price target on shares of Xometry from $110.00 to $114.00 and gave the stock an “overweight” rating in a research note on Wednesday. Eight research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $123.64.

More Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Q3 results beat expectations. Revenue rose 40% year over year to a record $252 million, while marketplace revenue grew 43%. Reported EPS of $0.28 topped the $0.19 consensus. The earnings coverage also highlighted 20% growth in active buyers, to 93,812. Xometry Q3 results Q3 investor takeaways
• Positive Sentiment: Several analysts raised targets, signaling continued optimism. JPMorgan lifted its target to $140 and kept an overweight rating; Citizens JMP raised its target to $135 and maintained market outperform; Citigroup raised its target to $132 and assigned a buy rating; and Rosenblatt raised its target to $130 with a buy rating. Citigroup rating JPMorgan rating Citizens JMP rating
• Neutral Sentiment: Not all target revisions imply meaningful upside. UBS raised its target to $108 but kept a neutral rating, placing its estimate below the quoted share price. RBC’s new $117 target and Cantor Fitzgerald’s $114 target indicate comparatively modest upside. UBS target revision RBC target revision
• Negative Sentiment: Profitability remains a watchpoint. Despite the EPS beat, the supplied results show a negative net margin, leaving investors to assess whether rapid growth can translate into sustained profits.

About Xometry

Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.